C-Reactive protein levels in patients on maintenance hemodialysis: reliability and reflection on the utility of single measurements

International Urology and Nephrology

Volumn 37, Issue 1, 2005, Pages 133-140

  Stigant, Caroline E ^a   Djurdjev, Ognjenka ^a   Levin, Adeera ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

C reactive protein; Cardiovascular disease; Hemodialysis; Inflammation; Inflammatory biomarkers

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGE; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONSTANTS AND COEFFICIENTS; DISEASE ACTIVITY; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; MALE; PROTEIN BLOOD LEVEL; REFERENCE VALUE; RELIABILITY; RISK ASSESSMENT; SAMPLING;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TIME FACTORS;

EID: 24144492778     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-004-2359-y     Document Type: Article

References (44)

1. V Panichi M Migliori S De Pietro et al. 2000 C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif 18 3 183-190 10.1159/000014417 10859421
2. DM Vigushin MB Pepys PN. Hawkins 1993 Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 91 4 1351-1357 8473487
3. R. Ross 1999 Atherosclerosis-an inflammatory disease. N Engl J Med 340 2 115-126 9887164
4. GA. Kaysen 2002 Role of inflammation and its treatment in ESRD patients. Blood Purif 20 1 70-80 10.1159/000046988 11803162
5. MC Martin-Mateo M Sanchez-Portugal S Iglesias et al. 1999 Oxidative stress in chronic renal failure. Ren Fail 21 2 155-167 10088176
6. T Miyata Y Wada Z Cai et al. 1997 mplication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 51 4 1170-1181 9083283
7. V Panichi M Migliori S De Pietro et al. 2000 The link of biocompatibility to cytokine production Kidney Int Suppl 76 S96-103 10.1046/j.1523-1755.2000.07612.x 10936805
8. V Panichi M Migliori S De Pietro et al. 2000 Plasma C-reactive protein in hemodialysis patients: A cross-sectional, longitudinal clinical survey. Blood Purif 18 1 30-36 10.1159/000014405 10686440
9. TF Parker RL Wingard L Husni et al. 1996 Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int 49 2 551-556 8821843
10. C de Filippi S Wasserman S Rosanio et al. 2003 Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 290 3 353-349 10.1001/jama.290.3.353 12865376
11. PM Ridker M Cushman MJ Stampfer et al. 1997 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 14 973-939 10.1056/NEJM199704033361401 9077376
12. JY Yeun RA Levine V Mantadilok et al. 2000 C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35 3 469-476 10692273
13. J Zimmermann S Herrlinger A Pruy et al. 1999 Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55 2 648-658 10.1046/j.1523-1755.1999.00273.x 9987089
14. A Kato M Odamaki T Takita et al. 2001 C-reactive protein is a predictor of short-term mortality in hemodialysis patients. Am J Nephrol 21 2 176-178 10.1159/000046243 11359028
15. K Iseki M Tozawa S Yoshi et al. 1999 Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 14 8 1956-1960 10.1093/ndt/14.8.1956 10462277
16. AR Qureshi A Alvestrand JC Divino-Filho et al. 2002 Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13 Suppl 1 S28-36 11792759
17. H Noh SW Lee SW Kang et al. 1998 Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 18 4 387-394 10505560
18. P Stenvinkel O Heimburger F Paultre et al. 1999 Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55 5 1899-1911 10.1046/j.1523-1755.1999.00422.x 10231453
19. GA Kaysen JA Dubin HG Muller et al. 2000 The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients The HEMO Study Group. Kidney Int 58 1 346-352 10.1046/ j.1523-1755.2000.00172.x
20. O Boenisch KD Ehmke A Heddergott et al. 2002 C-reactive-protein and cytokine plasma levels in hemodialysis patients. J Nephrol 15 5 547-551 12455722
21. WE Schouten MP Grooteman AJ Houte van et al. 2000 Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol Dial Transplant 15 3 379-384 10.1093/ndt/15.3.379 10692524
22. Tibshirani RJ, Bradley D. An Introduction to the Bootstrap: Chapman and Hall, Inc., 1993.
23. EM Macy TE Hayes RP. Tracy 1997 Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications. Clin Chem 43 1 52-58 8990222
24. GH Clark CG. Fraser 1993 Biological variation of acute phase proteins. Ann Clin Biochem 30 Pt 4 373-376 7691039
25. IS Ockene CE Matthews N Rifai et al. 2001 Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47 3 444-450 11238295
26. I. Kushner 2001 C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging. Cleve Clin J Med 68 6 535-537 11405614
27. AD Pradhan JE Manson JE Rossouw et al. 2002 Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 288 8 980-987 10.1001/jama.288.8.980 12190368
28. MH Wener PR Daum GM. McQuillan 2000 The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 27 10 2351-2359 11036829
29. EA Bermudez N Rifai JE Buring et al. 2002 Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 89 9 1117-1119 10.1016/S0002-9149(02)02284-1 11988205
30. TB Ledue N. Rifai 2001 High sensitivity immunoassays for C-reactive protein: Promises and pitfalls. Clin Chem Lab Med 39 11 1171-1176 10.1515/CCLM.2001.185 11831635
31. CG Fraser EK. Harris 1989 Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 27 5 409-437 2679660
32. B Campbell T Badrick R Flatman et al. 2002 Limited clinical utility of high-sensitivity plasma C-reactive protein assays. Ann Clin Biochem 39 Pt 2 85-88 10.1258/0004563021901757 11928769
33. B Bayes MC Pastor J Bonal et al. 2003 Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients. Nephrol Dial Transplant 18 1 106-112 10.1093/ndt/18.1.106 12480967
34. M Haubitz R. Brunkhorst 2001 C-reactive protein and chronic Chlamydia pneumoniae infection - long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 16 4 809-815 10.1093/ndt/16.4.809 11274279
35. C Lowbeer A Gutierrez SA Gustafsson et al. 2002 Elevated cardiac troponin T in peritoneal dialysis patients is associated with CRP and predicts all-cause mortality and cardiac death. Nephrol Dial Transplant 17 12 2178-2183 10.1093/ndt/17.12.2178 12454230
36. KA Herzig DM Purdie W Chang et al. 2001 Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 12 4 814-8121 11274243
37. TA Ikizler RL Wingard J Harvell et al. 1999 Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study. Kidney Int 55 5 1945-1951 10.1046/ j.1523-1755.1999.00410.x 10231458
38. C Zoccali FA Benedetto F Mallamaci et al. 2000 Inflammation is associated with carotid atherosclerosis in dialysis patients CREED Investigators. Cardiovascular risk extended evaluation in dialysis patients. J Hypertens 18 9 1207-1213
39. C-reactive protein and atherosclerosis in dialysis patients. Nephrol Dial Transplant 1998; 13(10): 2710-2711.
40. D Mezzano EO Pais E Aranda et al. 2001 Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60 5 1844-1850 10.1046/ j.1523-1755.2001.00998.x 11703602
41. JC Ayus D. Sheikh-Hamad 1998 Silent infection in clotted hemodialysis access grafts J Am Soc Nephrol 9 7 1314-1317 9644644
42. Nassar GM, Fishbane S, Ayus JC. Occult infection of old nonfunctioning arteriovenous grafts: A novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients. Kidney Int Suppl 2002; (80): 49-54.
43. RG Craig MA Spittle NW. Levin 2002 Importance of periodontal disease in the kidney patient Blood Purif 20 1 113-119 10.1159/000046994 11803168
44. I Kushner AR. Sehgal 2002 Is high-sensitivity C-reactive protein an effective screening test for cardiovascular risk? Arch Intern Med 162 8 867-869 10.1001/archinte.162.8.867 11966336